Clinical Trial: A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071532) titled 'A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants' on July 08.

Brief Summary: This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.

Study Start Date: July 08

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-932

Oral Capsule

DRUG: Itraconazole

Oral Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....